AVITA Medical Target Price

Analysts' average 12-month price target for AVITA Medical is $6.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.63

Average Target Price

$6.00

29.6% upside

1 analysts in the last 4 months

High: $6 | Low: $6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-15	Lake Street	$6	29.6% upside
2026-03-26	Northland Securities	$10	116% upside
2026-01-16	Lake Street	$3.5	24.4% downside
2025-10-17	Lake StreetFrank Takkinen	$4	13.6% downside
2025-01-08	Lake StreetBrooks O'Neil	$14	202.4% upside
2024-05-14	Piper SandlerMatt O'Brien	$9	94.4% upside

AVITA Medical (RCEL) FAQ

AVITA Medical (RCEL) currently reports a target price of $6. Use the charts on this page to explore AVITA Medical's target price history and peer comparisons.

Analysts' average 12-month price target for AVITA Medical is $6, about 29.6% upside from the current share price of $4.63. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $6, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AVITA Medical, and consider following RCEL for alerts when major investors trade the stock.